| D83 | Periods of homelessness linked to higher VACS Index among people living with HIV who use unregulated drugs | E-poster | People who use drugs (including by injection) |
| B37 | Persistence of drug-drug interaction problems with contemporary antiretroviral therapy. The case of ergotism | E-poster | Drug interactions |
| C48 | Persistence on oral pre-exposure prophylaxis (PrEP) among female sex workers in Durban, South Africa from 2016-2020 | E-poster | Adherence to HIV prevention strategies |
| B59 | Pharmacokinetics and safety of dispersible and immediate release FDC abacavir/dolutegravir/lamivudine in children with HIV weighing '¥14 kg: preliminary results from IMPAACT 2019 | E-poster | Pharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations |
| B59 | Pharmacokinetics, safety and acceptability of a single dose of abacavir/lamivudine/lopinavir/ritonavir (4-in-1) fixed-dose granule formulation in neonates: PETITE study | E-poster | Pharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations |
| D4 | Pilot implementation of a screening and linkage intervention to increase PrEP uptake in primary care | E-poster | Methods to improve provider quality, supply and adaptation of services |
| D22 | Piloting an integrated HIV/non-communicable disease (NCD) peer support programme in Cape Town | E-poster | Integration of HIV services with non-communicable disease programmes |
| D34 | Piloting social contracting mechanisms for government procurement of HIV services in the EECA region | E-poster | National financing initiatives and country ownership |
| D19 | Pivoting the use of e-Health & mHealth: assessing impact of peer via phone eservice delivery interventions on adherence, retention in care, viral load uptake and final infant outcomes during COVID-19 | E-poster | Use of e-health/m-health |
| A6 | Plasma IL-21 associates with HIV-1 Neutralising potency of polyclonal IgG in the periphery | On-demand oral abstract session | Humoral immunity (including broadly neutralizing antibodies) |